Cargando…
Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations
Based on DFT, MP2, and the density functional from Truhlar group (hybrid GGA: MPW1k) calculations for an acid-catalyzed hydrolysis of nine Kirby's N-alkylmaleamic acids and two atenolol prodrugs were designed. The calculations demonstrated that the amide bond cleavage is due to intramolecular n...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913492/ https://www.ncbi.nlm.nih.gov/pubmed/24526887 http://dx.doi.org/10.1155/2014/248651 |
_version_ | 1782302233005654016 |
---|---|
author | Karaman, Rafik Qtait, Alaa Dajani, Khulod Khayyat Abu Lafi, Saleh |
author_facet | Karaman, Rafik Qtait, Alaa Dajani, Khulod Khayyat Abu Lafi, Saleh |
author_sort | Karaman, Rafik |
collection | PubMed |
description | Based on DFT, MP2, and the density functional from Truhlar group (hybrid GGA: MPW1k) calculations for an acid-catalyzed hydrolysis of nine Kirby's N-alkylmaleamic acids and two atenolol prodrugs were designed. The calculations demonstrated that the amide bond cleavage is due to intramolecular nucleophilic catalysis by the adjacent carboxylic acid group and the rate-limiting step is determined based on the nature of the amine leaving group. In addition, a linear correlation of the calculated and experimental rate values has drawn credible basis for designing atenolol prodrugs that are bitterless, are stable in neutral aqueous solutions, and have the potential to release the parent drug in a sustained release manner. For example, based on the calculated B3LYP/6-31 G (d,p) rates, the predicted t (1/2) (a time needed for 50% of the prodrug to be converted into drug) values for atenolol prodrugs ProD 1-ProD 2 at pH 2 were 65.3 hours (6.3 hours as calculated by GGA: MPW1K) and 11.8 minutes, respectively. In vitro kinetic study of atenolol prodrug ProD 1 demonstrated that the t (1/2) was largely affected by the pH of the medium. The determined t (1/2) values in 1N HCl, buffer pH 2, and buffer pH 5 were 2.53, 3.82, and 133 hours, respectively. |
format | Online Article Text |
id | pubmed-3913492 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | Hindawi Publishing Corporation |
record_format | MEDLINE/PubMed |
spelling | pubmed-39134922014-02-13 Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations Karaman, Rafik Qtait, Alaa Dajani, Khulod Khayyat Abu Lafi, Saleh ScientificWorldJournal Research Article Based on DFT, MP2, and the density functional from Truhlar group (hybrid GGA: MPW1k) calculations for an acid-catalyzed hydrolysis of nine Kirby's N-alkylmaleamic acids and two atenolol prodrugs were designed. The calculations demonstrated that the amide bond cleavage is due to intramolecular nucleophilic catalysis by the adjacent carboxylic acid group and the rate-limiting step is determined based on the nature of the amine leaving group. In addition, a linear correlation of the calculated and experimental rate values has drawn credible basis for designing atenolol prodrugs that are bitterless, are stable in neutral aqueous solutions, and have the potential to release the parent drug in a sustained release manner. For example, based on the calculated B3LYP/6-31 G (d,p) rates, the predicted t (1/2) (a time needed for 50% of the prodrug to be converted into drug) values for atenolol prodrugs ProD 1-ProD 2 at pH 2 were 65.3 hours (6.3 hours as calculated by GGA: MPW1K) and 11.8 minutes, respectively. In vitro kinetic study of atenolol prodrug ProD 1 demonstrated that the t (1/2) was largely affected by the pH of the medium. The determined t (1/2) values in 1N HCl, buffer pH 2, and buffer pH 5 were 2.53, 3.82, and 133 hours, respectively. Hindawi Publishing Corporation 2014-01-12 /pmc/articles/PMC3913492/ /pubmed/24526887 http://dx.doi.org/10.1155/2014/248651 Text en Copyright © 2014 Rafik Karaman et al. https://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Article Karaman, Rafik Qtait, Alaa Dajani, Khulod Khayyat Abu Lafi, Saleh Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations |
title | Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations |
title_full | Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations |
title_fullStr | Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations |
title_full_unstemmed | Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations |
title_short | Design, Synthesis, and In Vitro Kinetics Study of Atenolol Prodrugs for the Use in Aqueous Formulations |
title_sort | design, synthesis, and in vitro kinetics study of atenolol prodrugs for the use in aqueous formulations |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913492/ https://www.ncbi.nlm.nih.gov/pubmed/24526887 http://dx.doi.org/10.1155/2014/248651 |
work_keys_str_mv | AT karamanrafik designsynthesisandinvitrokineticsstudyofatenololprodrugsfortheuseinaqueousformulations AT qtaitalaa designsynthesisandinvitrokineticsstudyofatenololprodrugsfortheuseinaqueousformulations AT dajanikhulodkhayyat designsynthesisandinvitrokineticsstudyofatenololprodrugsfortheuseinaqueousformulations AT abulafisaleh designsynthesisandinvitrokineticsstudyofatenololprodrugsfortheuseinaqueousformulations |